In preclinical studies conducted on cynomolgus monkeys it has shown agonistic activity to human and cynomolgus GLP-1 receptors and improved glucose tolerance by stimulating insulin secretion, and it exhibited an anti-feeding activity like exenatide
However, stronger doesnt mean right for everyone. Individual responses vary significantly, and semaglutide produces clinically meaningful results for the majority of patients who take it
Reconsidering repurposing: long-term metformin treatment impairs cognition in Alzheimers model mice
This keeps metabolism steady and encourages long-term success
Slinin Y, Ishani A, Rector T, Fitzgerald P, MacDonald R, Tacklind J, et al
Gastrointestinal side effects and altered dietary patterns could also play a role